HPV Vaccinations: Coverage, Challenges, and Strategies

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".

Deadline for manuscript submissions: 30 September 2026 | Viewed by 1482

Editors


E-Mail Website
Guest Editor
“Villa Sofia Cervello” Hospital, University of Palermo, 90133 Palermo, Italy
Interests: gynecology; endoscopy; hysteroscopy; laparoscopy; papillomavirus; colposcopy; HPV vaccines; endometriosis; infertility
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor Assistant
Department of Gynecology and Obstetrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 22240-003, RJ, Brazil
Interests: gestational trophoblastic neoplasia; gynecologic neoplasms; preterm birth; preventive medicine and public health

Special Issue Information

Dear Colleagues,

Human papillomavirus (HPV) infection is one of the most prevalent sexually transmitted infections worldwide and a leading cause of cervical cancer, as well as other anogenital and oropharyngeal malignancies. Since the introduction of prophylactic HPV vaccines, remarkable progress has been made in reducing HPV prevalence and HPV-related disease burden. However, vaccination coverage remains highly heterogeneous across regions and populations, reflecting disparities in access, vaccine hesitancy, and limitations in public health infrastructure.

Despite the proven safety and efficacy of HPV vaccination, several barriers continue to hinder its universal implementation, including socioeconomic inequities, misinformation, gender bias, and programmatic challenges in reaching adolescents and underserved communities. Furthermore, there is a pressing need to optimize strategies for catch-up vaccination, integrate HPV vaccination within broader sexual and reproductive health programs, and evaluate long-term real-world effectiveness and immunological correlates of protection.

This Special Issue aims to gather current evidence, innovations, and perspectives on HPV vaccination worldwide. We welcome original research, systematic reviews, and expert opinions that explore (i) global and regional trends in vaccine coverage, (ii) determinants of vaccine acceptance and hesitancy, (iii) health policy and implementation strategies to improve coverage, (iv) long-term impact and surveillance data, and (v) novel approaches to education, communication, and equity in HPV prevention.

Dr. Gloria Calagna
Guest Editor

Dr. Gabriela Paiva
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • human papillomavirus
  • cervical cancer prevention
  • vaccination
  • vaccine coverage
  • public health strategies
  • adolescent immunization
  • health equity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Back to TopTop